Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $53.1 million.

  • Select Medical Holdings' Capital Expenditures rose 477.28% to $53.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.6 million, marking a year-over-year increase of 647.5%. This contributed to the annual value of $222.2 million for FY2024, which is 306.41% down from last year.
  • Latest data reveals that Select Medical Holdings reported Capital Expenditures of $53.1 million as of Q3 2025, which was up 477.28% from $64.7 million recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Capital Expenditures registered a high of $64.7 million during Q2 2025, and its lowest value of $36.7 million during Q2 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $52.5 million (2024), whereas its average is $52.2 million.
  • In the last 5 years, Select Medical Holdings' Capital Expenditures soared by 4261.49% in 2021 and then crashed by 1430.61% in 2022.
  • Over the past 5 years, Select Medical Holdings' Capital Expenditures (Quarter) stood at $55.2 million in 2021, then grew by 0.18% to $55.3 million in 2022, then increased by 9.68% to $60.6 million in 2023, then rose by 4.66% to $63.4 million in 2024, then dropped by 16.28% to $53.1 million in 2025.
  • Its last three reported values are $53.1 million in Q3 2025, $64.7 million for Q2 2025, and $52.3 million during Q1 2025.